Filing Details

Accession Number:
0001140361-13-012264
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-13 15:33:58
Reporting Period:
2013-03-12
Filing Date:
2013-03-13
Accepted Time:
2013-03-13 15:33:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1275187 Angiodynamics Inc ANGO Surgical & Medical Instruments & Apparatus (3841) 113146460
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1254189 Vincent Bucci 14 Plaza Drive
Latham NY 12110
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-12 40,000 $10.78 78,696 No 4 P Direct
Common Stock Acquisiton 2013-03-12 35,000 $10.76 38,000 No 4 P Indirect By joint account with wife
Common Stock Acquisiton 2013-03-12 10,000 $10.80 13,000 No 4 P Indirect By trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By joint account with wife
No 4 P Indirect By trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,000 Indirect By daughter
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.65 to $10.93, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.71 to $10.80, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 2.
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.71 to $10.90, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 3.
  4. Held by the Susan C. Bucci Revocable Trust, of which the reporting person is a co-trustee.